New hope for Tough-to-Treat lung cancer: drug combo trial seeks to extend remission

NCT ID NCT05718323

Summary

This trial is testing whether adding a drug called niraparib to standard immunotherapy maintenance can help control advanced small cell lung cancer for longer. It is for patients whose cancer has a specific biomarker (SLFN11-positive) and has not worsened after initial chemotherapy-immunotherapy. The main goal is to see if this combination keeps the cancer from progressing for at least three months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCLC, EXTENSIVE STAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • AULSS2 Marca Trevigiana Treviso

    NOT_YET_RECRUITING

    Treviso, Italy

    Contact Email: •••••@•••••

  • Bürgerspital Solothurn

    RECRUITING

    Solothurn, Switzerland

    Contact Email: •••••@•••••

  • CHU - Angers

    RECRUITING

    Angers, France

    Contact Email: •••••@•••••

  • Caen - CHU

    RECRUITING

    Caen, France

    Contact Email: •••••@•••••

  • Centre Hospitalier d'Avignon

    RECRUITING

    Avignon, France

    Contact Email: •••••@•••••

  • Centre Hospitalier du Valais Romand

    RECRUITING

    Sion, Switzerland

    Contact Email: •••••@•••••

  • Complejo Hospitalario Universitario a Coruña

    NOT_YET_RECRUITING

    A Coruña, Spain

    Contact

  • Complejo Hospitalario de Jaén

    RECRUITING

    Jaén, Spain

    Contact

  • Hospital Universitario Puerta de Hierro

    RECRUITING

    Madrid, Spain

    Contact

  • Inselspital Bern

    RECRUITING

    Bern, Switzerland

    Contact Email: •••••@•••••

  • Instituto Europeo di Oncologia (IEO)

    NOT_YET_RECRUITING

    Milan, Italy

    Contact Email: •••••@•••••

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)

    RECRUITING

    Meldola, Italy

    Contact Email: •••••@•••••

  • Kantonsspital Baden

    RECRUITING

    Baden, Switzerland

    Contact Email: •••••@•••••

  • Kantonsspital St. Gallen

    RECRUITING

    Sankt Gallen, Switzerland

    Contact Email: •••••@•••••

  • Kantonsspital Winterthur

    RECRUITING

    Winterthur, Switzerland

    Contact Email: •••••@•••••

  • Lyon - Centre Léon Bérard

    NOT_YET_RECRUITING

    Lyon, France

    Contact Email: •••••@•••••

  • Santa Maria della Misericordia Hospital

    RECRUITING

    Perugia, Italy

    Contact Email: •••••@•••••

  • University Hospital Basel

    RECRUITING

    Basel, Switzerland

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.